Blackstone Group »

Ligand Pharmaceuticals In shares owned by Blackstone Group

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Blackstone Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $282k 1.4k 199.65

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Corebridge Finl (CRBG)
FirstEnergy (FE)
Legence Corp Cl A (LGN)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Williams Companies (WMB)
MPLX Com Unit Rep Ltd (MPLX)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Enbridge (ENB)
Kinder Morgan (KMI)
Energy Transfer Com Ut Ltd Ptn (ET)
Kinetik Holdings Com New Cl A (KNTK)
Cheniere Energy Com New (LNG)
PNM Resources (TXNM)

View all positions for Blackstone Group

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Vanguard Portfolio Management
Henderson Group
Vanguard Capital Management
Invesco
State Street Corporation
FMR
Nomura Asset Management International
Franklin Resources
Chicago Capital
Geode Capital Management
Massachusetts Financial Services
Congress Asset Management
Stephens Investment Management Group

View all funds holding Ligand Pharmaceuticals In